Sodium Polystyrene Sulfonate Aspiration Case Report
Author Information
Author(s): Luis F Gonzalez-Cuyar, Nathaniel B Cresswell, Allen P Burke
Primary Institution: University of Maryland School of Medicine
Hypothesis
Can sodium polystyrene sulfonate aspiration lead to severe complications in terminally ill patients?
Conclusion
Sodium polystyrene sulfonate aspiration was identified as the immediate cause of death in a patient with compromised pulmonary function.
Supporting Evidence
- Sodium polystyrene sulfonate is commonly used to treat high potassium levels in patients with renal failure.
- The patient developed severe hypoxemia and expired shortly after oral administration of SPS.
- Histological examination revealed extensive intraalveolar deposition of SPS crystals.
Takeaway
This report shows that a medicine used to lower potassium can cause serious problems if it gets into the lungs, especially in very sick people.
Methodology
Histological examination of lung tissue was performed post-mortem.
Limitations
The case report is based on a single patient, limiting generalizability.
Participant Demographics
A 45-year-old male with a history of HIV, Hepatitis B, and Hepatitis C.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website